臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"pei jer chen"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 646-670 / 883 (共36頁)
<< < 21 22 23 24 25 26 27 28 29 30 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2021-07-03T03:33:28Z	Gender difference in the association between metabolic factors and hepatocellular carcinoma	Chen C.-L.; Kuo M.-J.; Ming-Fang Yen A.; Yang W.-S.; Kao J.-H.; PEI-JER CHEN; Chen H.-H.
臺大學術典藏	2021-07-03T03:33:28Z	Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related Cirrhosis	Su T.-H.; Peng C.-Y.; Tseng T.-C.; Yang H.-C.; Liu C.-J.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:28Z	A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice	Zhang T.-Y.; Guo X.-R.; Wu Y.-T.; Kang X.-Z.; Zheng Q.-B.; Qi R.-Y.; Chen B.-B.; Lan Y.; Wei M.; Wang S.-J.; Xiong H.-L.; Cao J.-L.; Zhang B.-H.; Qiao X.-Y.; Huang X.-F.; Wang Y.-B.; Fang M.-J.; Zhang Y.-L.; Cheng T.; Chen Y.-X.; Zhao Q.-J.; Li S.-W.; Ge S.-X.; PEI-JER CHEN; Zhang J.; Yuan Q.; Xia N.-S.
臺大學術典藏	2021-07-03T03:33:28Z	Asialo GM1-positive liver-resident CD8 T cells that express CD44 and LFA-1 are essential for immune clearance of hepatitis B virus	Sung C.-C.; Horng J.-H.; Siao S.-H.; Chyuan I.-T.; Tsai H.-F.; PEI-JER CHEN; Hsu P.-N.
臺大學術典藏	2021-07-03T03:33:27Z	Complement C1q mediates the expansion of periportal hepatic progenitor cells in senescence-associated inflammatory liver	Ho T.-C.; Wang E.-Y.; Yeh K.-H.; Jeng Y.-M.; Horng J.-H.; Wu L.-L.; Chen Y.-T.; Huang H.-C.; Hsu C.-L.; PEI-JER CHEN; Yeh S.-H.; Chen D.-S.
臺大學術典藏	2021-07-03T03:33:27Z	Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy	Tseng T.-C.; Peng C.-Y.; Hsu Y.-C.; Su T.-H.; Wang C.-C.; Liu C.-J.; Yang H.-C.; Yang W.-T.; Lin C.-H.; Yu M.-L.; Lai H.-C.; Tanaka Y.; Nguyen M.H.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:27Z	Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan	Liu C.-H.; Liu C.-J.; Hung C.-C.; Hsieh S.-M.; Su T.-H.; Sun H.-Y.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:26Z	HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis	Tseng T.-C.; Liu C.-J.; Chang C.T.; Su T.-H.; Yang W.-T.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:26Z	Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment	Liu C.-H.; Yang S.-S.; Peng C.-Y.; Lin W.-T.; Liu C.-J.; Su T.-H.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:26Z	HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice	Horng J.-H.; Lin W.-H.; Wu C.-R.; Lin Y.-Y.; Wu L.-L.; Chen D.-S.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:33:26Z	Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antivirals	Liu C.-H.; Lee M.-H.; Lin J.-W.; Liu C.-J.; Su T.-H.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:25Z	Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19)	Chang F.-Y.; Chen H.-C.; PEI-JER CHEN; Ho M.-S.; Hsieh S.-L.; Lin J.-C.; Liu F.-T.; Sytwu H.-K.
臺大學術典藏	2021-07-03T03:33:25Z	Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection	Cheng X.; Uchida T.; Xia Y.; Umarova R.; Liu C.-J.; PEI-JER CHEN; Gaggar A.; Suri V.; M?cke M.M.; Vermehren J.; Zeuzem S.; Teraoka Y.; Osawa M.; Aikata H.; Tsuji K.; Mori N.; Hige S.; Karino Y.; Imamura M.; Chayama K.; Liang T.J.
臺大學術典藏	2021-07-03T03:33:25Z	2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population	Yu M.-L.; PEI-JER CHEN; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; Liu C.-H.; Liu C.-J.; Peng C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L.
臺大學術典藏	2021-07-03T03:33:24Z	Performance of commercially available anti-HDV enzyme-linked immunosorbent assays in Taiwan	Lin G.-Y.; Wu Y.-L.; Wang C.-S.; Ko C.-Y.; Chen C.-H.; PEI-JER CHEN; Peng P.-H.; Hsu C.-W.
臺大學術典藏	2021-07-03T03:33:24Z	The origin and underlying driving forces of the SARS-CoV-2 outbreak	Chaw S.-M.; Tai J.-H.; Chen S.-L.; Hsieh C.-H.; Chang S.-Y.; Yeh S.-H.; Yang W.-S.; PEI-JER CHEN; Wang H.-Y.
臺大學術典藏	2021-07-03T03:33:24Z	Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing	Yang Y.-C.; Chen Y.-H.; Kao J.-H.; Ching C.; Liu I.-J.; Wang C.-C.; Tsai C.-H.; Wu F.-Y.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Yang H.-C.
臺大學術典藏	2021-07-03T03:33:23Z	Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data	Hong C.-M.; Liu C.-H.; Su T.-H.; Yang H.-C.; PEI-JER CHEN; Chen Y.-W.; Kao J.-H.; Liu C.-J.
臺大學術典藏	2021-07-03T03:33:23Z	2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations	Yu M.-L.; PEI-JER CHEN; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; Liu C.-H.; Liu C.-J.; Peng C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L.
臺大學術典藏	2021-07-03T03:33:23Z	The role of phylogenetic analysis in clarifying the infection source of a COVID-19 patient	Wang J.-T.; Lin Y.-Y.; Chang S.-Y.; Yeh S.-H.; Hu B.-H.; PEI-JER CHEN; Chang S.-C.
臺大學術典藏	2021-07-03T03:33:23Z	Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer	Su T.-H.; Tseng T.-C.; Liu C.-J.; Chou S.-W.; Liu C.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Chen C.-L.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:22Z	Twelve weeks of ledipasvir/sofosbuvir all-oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trials	Asahina Y.; Liu C.-J.; Gane E.; Itoh Y.; Kawada N.; Ueno Y.; Youn J.; Wang C.-Y.; Llewellyn J.; Matsuda T.; Gaggar A.; Mo H.; Dvory-Sobol H.; Crans G.; Chuang W.-L.; PEI-JER CHEN; Enomoto N.
臺大學術典藏	2021-07-03T03:33:22Z	Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan	Su H.-J.; Kao J.-H.; Tseng T.-C.; Yang H.-C.; Su T.-H.; PEI-JER CHEN; Liu C.-J.
臺大學術典藏	2021-07-03T03:33:22Z	Disease burden from foodborne illnesses in Taiwan, 2012–2015	Lai Y.-H.; Chung Y.-A.; Wu Y.-C.; Fang C.-T.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:33:22Z	Elimination of hepatitis B in highly endemic settings: Lessons learned in Taiwan and challenges ahead	Liu C.-J.; PEI-JER CHEN

顯示項目 646-670 / 883 (共36頁)
<< < 21 22 23 24 25 26 27 28 29 30 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :2828138
	造訪人次 : 32089243 線上人數 : 1310 教育部委託研究計畫計畫執行:國立臺灣大學圖書館